Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Biden, Medicare
Medicare May Soon Cover Ozempic, Wegovy Under New Biden Proposal
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.
Opinion
19m
Opinion
The Case for Getting the Government to Pay for Wegovy
The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...
Wall Street Journal on MSN
1h
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
The White House said Tuesday it is moving to make
Medicare
and Medicaid cover anti-obesity drugs such as Novo Nordisk’s ...
phillyvoice.com
19h
Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
MORE: Vaping, even without nicotine, can have harmful cardiovascular effects Ozempic and
Wegovy
, from Novo Nordisk, and ...
3h
on MSN
Medicare Could Pay for Wegovy. Don’t Count On It.
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Joe Biden
Ozempic
United States Department of Health and Human Services
Feedback